Ask me later

Ask me later

How likely are you to recommend Redeye to a friend or colleague?

1

2

3

4

5

6

7

8

9

10

Not likely

Very likely

Not likely

1

2

3

4

5

6

7

8

9

10

Very likely

Message received

Thanks again for rating us!

Kontigo Care Q2’22: Strong sales and 16% EBIT margin

2022-08-26

10:13

JG

Jessica Grunewald

Redeye comments on Kontigo Care’s Q2’22 report where sales came in slightly higher than we estimated. The company continues to impress with solid revenue growth of 23% Y/Y and 8% Q/Q. This was the 9th consecutive report with net sales growth, continuing the solid growth path.

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers